Ligand validation:4RE2

EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4RE2_EPE_A_503	21%	37%	0.209	0.817	0.86	1.68	1	3	0	0	100%	1
4JHO_EPE_A_500	65%	36%	0.142	0.946	0.88	1.69	1	4	0	0	100%	0.5
4JIE_EPE_A_507	39%	30%	0.221	0.927	0.72	2.15	-	4	2	0	100%	0.9
4RE3_EPE_A_505	15%	36%	0.307	0.869	0.65	1.92	-	5	4	0	100%	0.7
4RE4_EPE_A_506	9%	39%	0.29	0.773	0.69	1.73	1	4	2	0	100%	0.9
4WX4_EPE_A_302	99%	53%	0.064	0.994	0.99	0.82	1	-	0	0	100%	1
2F9R_EPE_B_701	99%	45%	0.061	0.989	0.62	1.54	-	2	0	0	100%	1
1VSI_EPE_A_261	98%	18%	0.058	0.984	1.64	2.09	1	6	1	0	100%	1
1XX1_EPE_D_2004	98%	29%	0.063	0.987	0.79	2.15	1	6	1	0	100%	1
4WYD_EPE_B_503	98%	45%	0.065	0.989	0.93	1.23	1	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.